These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

179 related items for PubMed ID: 6104494

  • 21. Timolol maleate, a new beta-adrenergic receptor blocking agent.
    Hall RA, Robson RD, Share NN.
    Arch Int Pharmacodyn Ther; 1975 Feb; 213(2):251-63. PubMed ID: 238479
    [Abstract] [Full Text] [Related]

  • 22. Bis-arenoxypropanolamines as potential beta-adrenolytics: a reinvestigation.
    Da Re P, Valenti P, Fabbri G, Frigeni V, Reggiani A, Della Bella D.
    Drugs Exp Clin Res; 1988 Feb; 14(11):687-92. PubMed ID: 2907738
    [Abstract] [Full Text] [Related]

  • 23. The effect of racemic propranolol, dextro-propranolol and racemic practolol on the human and canine cardiac transmembrane action potential (beta blockade and the cardiac action potential).
    Coltart DJ, Meldrum SJ.
    Arch Int Pharmacodyn Ther; 1971 Jul; 192(1):188-97. PubMed ID: 4398411
    [No Abstract] [Full Text] [Related]

  • 24. [Cellular mechanism of the antiarrhythmic action of propranolol].
    Kwiatkowska B, Czarnecka M, Lewartowski B.
    Acta Physiol Pol; 1970 Jul; 21(4):441-54. PubMed ID: 5452921
    [No Abstract] [Full Text] [Related]

  • 25. Comparative beta adrenoreceptor blocking effect of propranolol and penbutalol. Preliminary observations.
    Khanna PK, Balasubramanian V, Chatterji JC, Hoon RS.
    J Assoc Physicians India; 1978 Mar; 26(3):143-6. PubMed ID: 32165
    [No Abstract] [Full Text] [Related]

  • 26. [Pharmacological studies of celiprolol: III. Effects of celiprolol on the cardiovascular system and renal function, and its antiarrhythmic effects].
    Ochi S, Kimura Y, Matsuzaki T, Hayashi S, Motonaga A, Tanaka M, Fukui H, Yamazaki A, Matsumura K, Miura A.
    Nihon Yakurigaku Zasshi; 1990 Apr; 95(4):209-27. PubMed ID: 1973400
    [Abstract] [Full Text] [Related]

  • 27. [Pharmacological characterization of the new highly potent beta-adrenergic receptor blocker soquinolol].
    Gries J, Unger L, Einig H, Friedrich L, Hofmann HP, Kreiskott H, Lehmann HD, von Philipsborn G, Wuppermann D, Zimmermann F.
    Arzneimittelforschung; 1988 Sep; 38(9):1271-9. PubMed ID: 2906243
    [Abstract] [Full Text] [Related]

  • 28. The effect of single doses of penbutolol and propranolol L.A. on psychomotor performance.
    Broadhurst AD, Monaghan AT.
    Br J Clin Pharmacol; 1984 May; 17(5):591-4. PubMed ID: 6733006
    [Abstract] [Full Text] [Related]

  • 29. [Relation between the changes of cellular electrogenesis and beta-blocking activity of 4 optical isomers of butydrine].
    Musso E, Taccardi B.
    Atti Soc Ital Cardiol; 1969 Jan 21; 2():268-9. PubMed ID: 5406541
    [No Abstract] [Full Text] [Related]

  • 30. L-3,4-(3-3,4-dimethoxyphenethylamino-2-hydroxypropoxy)-phenyl- crotonic acid nitrile.HCl (Hoe 224), a beta-blocking agent with high beta 1-selectivity.
    Lindner E.
    Arzneimittelforschung; 1984 Jan 21; 34(3):270-6. PubMed ID: 6145430
    [Abstract] [Full Text] [Related]

  • 31. Electrophysiological evaluation of anesthetic actions of some beta-adrenergic blockers on guinea-pig cardiac muscles.
    Washizu Y.
    Arch Int Pharmacodyn Ther; 1973 Apr 21; 202(2):263-9. PubMed ID: 4144372
    [No Abstract] [Full Text] [Related]

  • 32. Proceedings: The antiarrhythmic activity of the prostaglandins A2, E2, and F2alpha.
    Kaiser J, Schoelkens B.
    Naunyn Schmiedebergs Arch Pharmacol; 1974 Apr 21; 282(Suppl):suppl 282:R44. PubMed ID: 4276580
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Inotropic and electrophysiological effects of AB--2, a new antiarrhythmic agent, on isolated cardiac preparations.
    Beresewicz A, Pytkowski B, Sedek G, Zdanowski K.
    Pol J Pharmacol Pharm; 1983 Apr 21; 35(3):223-32. PubMed ID: 6651921
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.